Avalo Therapeutics Overview

Avalo Therapeutics Operating Income

Operating Income for AVTX.

Quarterly Operating Income

$-20901000.00

↑ 42.48% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-79158000.00

↑ 57.33% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin